Trial Profile
Investigation for the effect of duloxetine on adolescent depression; Ver. 2
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2017
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms E-DAD
- 30 Jun 2017 Planned End Date changed from 31 May 2017 to 31 Mar 2017.
- 30 Jun 2017 Status changed from recruiting to discontinued.
- 12 Apr 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.